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Background: We investigated how relevant and responsive scientists and research ethics committee (REC)
members considered the research protocol review processes for health research practice in Uganda.
Methods: Interviews were conducted with five scientists and five REC members. Data were analysed
thematically.
Results: How much to compensate for time, the amount of study information shared with volunteers and
sample storage for future unknown research were areas of concern for RECmembers. Delays in getting feedback
concerned scientists.
Conclusions: Researchers and REC members need to hold regular discussions to ensure the review process is
relevant and responsive.
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Introduction
Scientists and research ethics committee (REC) members have
expressed concerns that the review process does not factor in
certain aspects of trial conduct among vulnerable populations,
such as compensation for time, amount of study information
and future sample storage. This may lead to some friction be-
tween the two groups if not discussed.1 We investigated how the
ethics review process might become more relevant and respon-
sive to health research practice in Uganda and in thewider field of
applied research ethics.
Methods
Following ethical approval for the study, we conducted in-depth
interviews with five Uganda Virus Research Institute (UVRI) REC
members of different disciplines: statistician, public health spe-
cialist, social scientist, clinician and a community representative
and five scientists involved in human immunodeficiency virus
(HIV) clinical trials with experience submitting protocols for re-
view. Study information was shared and written informed con-
sent was obtained. A semi-structured interview topic guide was
used for individual interviews. Interviews were digitally recorded
after participants had given their consent for recording. Data
analysis was thematic following the patterns coming through
the data; the process of analysis was managed using NVivo (QSR
International, Melbourne, VC, Australia).
Results
The REC members described the review process as ‘formal’. Each
committee member was tasked with reviewing the whole proto-
col, although a few members with expertise in the given study
topic area and discipline would take the lead in the discussion.
REC members argued that scientists should facilitate the review
process by ensuring their applications are clear, clarifying con-
cepts and shortening the participant information documents.
REC members reported a number of challenges: ensuring in-
formation sheets and consent forms were clear and could be
understood by the targeted study populations; decisions about
appropriate compensation to study participants; researcher re-
quests for sample storage without clear reasons for the purpose
being explained; managing the response from scientists who dis-
puted the REC feedback on reviewed protocols; funding limits in
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the field of ethics, which meant the training of committees and
researchers in research ethics was limited; and the absence of
national policy guidelines on research ethics. The issue of offer-
ing compensation, especially in poor communities or even among
vulnerable participants, is a design decision the RECmembers had
to discuss and was noted as ‘difficult’.
The REC members noted that while not a common practice,
there were occasions when they requested a change to certain
protocols and the collaborating partners working with UVRI
researchers undermined their suggestions, going to a different
review board for a more favourable ethics review and then
proceeding with the study. This threatened ethical standards
and underlined the importance of shared standards followed by
different RECs in Uganda.
The review process was seen by the scientists as a very
formal legalistic process. They reported that they regularly had
to wait for a long time for approval before they could start their
research. The challenges reported by scientists included waiting
for a long time before receiving approval for a study, lack of
a formal curriculum to train their research teams, difficulty in
assessing with confidence whether a participant had understood
the study information and having to communicate scientific
terms in the informed consent documents. It was noted that
comprehension of the study purpose and procedures was not
dependent on literacy skills; attention to ensuring the process of
obtaining consent was clear and understandable was essential
for all.2 However, the amount of information required in consent
documents (sometimes required by funders and study sponsors)
remained a challenge. There continues to be discussion over the
content and length of such documents.3
Discussion
Conducting HIV clinical trials raises ethical and scientific design is-
sues that may impact on the ethics review process. A therapeutic
misconception, where a volunteer agrees to take part in research
as a surrogate for health service provision that may not normally
be available where health services are limited, was of concern to
both researchers and REC members.
Approving storage of samples on the basis of ‘broad consent’
without the researchers stating clearly what the samples would
be used for, is a critical area for review, requiring the RECmembers
to weigh the costs and benefits of the research for study volun-
teers and question whether, if they approved, they are ‘doing the
right thing’.4 The development of a guiding framework on these
aspects of ethical conduct to be used across all RECs would assist
in this decision making.
Conclusions
The practical experiences shared by participants in this study can
help improve communication between RECs and researchers by
highlighting debates and dilemmas raised by REC members in
handling the ethics review process. The protocol review process
is evolving and there is a need for researchers and REC mem-
bers to hold regular discussions to ensure the review process is
relevant and responsive to health research practice in a given
research context.
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